[Zhaopin Limited Reports Fourth Quarter and Fiscal Year 2016 Financial Results 1 BEIJING, August 21, 2016 /PRNewswire/ -- Zhaopin Limited (NYSE: ZPIN) ("Zhaopin" or the "Company"), a leading career platform Throughout the release, one represents two Class A ordinary shares. Fiscal year refers to the 12 months ended June 30. Fourth Quarter of Fiscal Year 2016 Financial Highlights Percentage growth] []
[FORM 10−Q (Mark One) June 30, 2016 For the quarterly period ended: For the transition period from _____________ to _____________ 001-32898 CHINA BAK BATTERY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) BAK Industrial Park, Meigui Street Huayuankou Economic Zone Dalian City, Liaoning Province, China, 116450 (86)(411)-3918-5985 _____________________________________________________ Large accelerated filer [ ]] [CERTIFICATIONS I, Yunfei Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Wenwu Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Yunfei Li Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Wenwu Wang Interim Chief Financial Officer (Principal Financial and Accounting Officer)]
[ITEM 1. FINANCIAL STATEMENTS CHINA COMMERCIAL CREDIT, INC. CONSOLIDATED BALANCE SHEETS June 30, December 31, 2016 2015 (Unaudited) ASSETS Cash $ 1,369,621 $ 306,401 Restricted cash 10,031 388,361 Notes receivable 97,828 15,404 Loans receivable, net of allowance for loan losses $54,488,203 and $55,595,653 for June 30, 2016 and December 31, 2015, respectively 5,666,417 7,481,067 Investment in direct financing lease, net] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Mingjie Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Long Yi, certify that: 1 I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Mingjie Zhao Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]
[Xinyuan Real Estate Co., Ltd. and Subsidiaries CONTENTS Pages Condensed consolidated balance sheets as of December 31, 2015 (audited) and June 30, 2016 (unaudited) F-2 Condensed consolidated statements of comprehensive income for the six months ended June 30, 2015 and 2016 (unaudited) F-4 Condensed consolidated statements of cash flows for the six months ended June 30, 2015 and 2016 (unaudited)] [Selected financial data Our Selected Consolidated Financial Data The selected consolidated financial data should be read in conjunction with, and are qualified in their entirety by reference to, our unaudited condensed consolidated financial statements and related notes and the "Operating and Financial Review and Prospects” included elsewhere in this report. Six months ended June 30, 2015 2016 US$ US$ (Unaudited)] [OPERATING AND FINANCIAL REVIEW AND PROSPECTS A. Operating Results Overview Our total revenue, derived primarily from sales of residential real estate, has increased from US$441.8 million in the first six months of 2015 to US$612.0 million in the first six months of 2016. Our net income was US$24.7 million and US$32.6 million, respectively, for the same periods. We acquire land] []
[ITEM 1. FINANCIAL STATEMENTS CHINA COMMERCIAL CREDIT, INC. CONSOLIDATED BALANCE SHEETS June 30, December 31, 2016 2015 (Unaudited) ASSETS Cash $ 1,369,621 $ 306,401 Restricted cash 10,031 388,361 Notes receivable 97,828 15,404 Loans receivable, net of allowance for loan losses $54,488,203 and $55,595,653 for June 30, 2016 and December 31, 2015, respectively 5,666,417 7,481,067 Investment in direct financing lease, net] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Mingjie Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Long Yi, certify that: 1 I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Mingjie Zhao Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]
[Xinyuan Real Estate Co., Ltd. and Subsidiaries CONTENTS Pages Condensed consolidated balance sheets as of December 31, 2015 (audited) and June 30, 2016 (unaudited) F-2 Condensed consolidated statements of comprehensive income for the six months ended June 30, 2015 and 2016 (unaudited) F-4 Condensed consolidated statements of cash flows for the six months ended June 30, 2015 and 2016 (unaudited)] [Selected financial data Our Selected Consolidated Financial Data The selected consolidated financial data should be read in conjunction with, and are qualified in their entirety by reference to, our unaudited condensed consolidated financial statements and related notes and the "Operating and Financial Review and Prospects” included elsewhere in this report. Six months ended June 30, 2015 2016 US$ US$ (Unaudited)] [OPERATING AND FINANCIAL REVIEW AND PROSPECTS A. Operating Results Overview Our total revenue, derived primarily from sales of residential real estate, has increased from US$441.8 million in the first six months of 2015 to US$612.0 million in the first six months of 2016. Our net income was US$24.7 million and US$32.6 million, respectively, for the same periods. We acquire land] []
[Dehaier Medical Systems Ltd. Completes $20 Million Strategic Financing with Hangzhou Liaison Interactive Information Technology Co. Ltd. About Dehaier Medical Systems Ltd. http://www.dehaier.com.cn Dehaier Medical develops, markets and sells medical products, including medical devices and wearable sleep respiratory products in China and international markets. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components.] []
[FORM 10-Q (Mark One) June 30, 2016 For the quarterly period ended: 001-34449 Commission File No. AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) BeihuanZhong Road Junan County Shandong, Peoples Republic of China, 276600 (86) 539-7317959 Large accelerated filer [_] Accelerated filer [_] Non-accelerated filer [_] Smaller reporting company [X] (Do] [CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER I, Si Chen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2016 of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATIONS OF CHIEF FINANCIAL OFFICER I, Zhanhai Yang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2016 of American Lorain Corporation 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.]
[Dehaier Medical Systems Ltd. Completes $20 Million Strategic Financing with Hangzhou Liaison Interactive Information Technology Co. Ltd. About Dehaier Medical Systems Ltd. http://www.dehaier.com.cn Dehaier Medical develops, markets and sells medical products, including medical devices and wearable sleep respiratory products in China and international markets. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components.] []
